Image via Endpoints News
Takeda: Product Launch
Takeda's oral plaque psoriasis drug (Zasocitinib) demonstrated superiority over Bristol Myers Squibb's Sotyktu in Phase 3 head-to-head clinical trial, validating the company's $4 billion investment in this therapeutic area.
Source: Endpoints News
The leadership read
Will need commercial leadership (VP Commercial/Medical Affairs), regulatory affairs specialists, sales and marketing teams, and commercial operations roles to prepare for market launch and compete against established competitor.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Americas signal share is easing (-9.8pts).
MitchelLake in this thematic
Our work · 2020
Chief Technology Officer
Splitit
Americas · Fintech · payments · fintech
Our work · 2020
Senior Product Manager
Yanka Industries Inc. (Masterclass)
Americas · Sport, Media & Entertainment · product · edtech
Our work · 2019
Director of Product
Tubi, Inc.
Americas · Sport, Media & Entertainment · product · streaming